India easing lockdowns on cases and not vaccines risky strategy: UK study

Strategy increases chances of fresh outbreaks that would further delay economic recovery, says Oxford Economics.

coronavirus
People visit a market that reopened on Saturday, June 18, 2021, after Delhi eased restrictions to slow down Covid-19. (PTI Photo/Arun Sharma)
Jaiveer Shekhawat | Bloomberg
2 min read Last Updated : Jun 24 2021 | 10:18 AM IST
The rush by India’s states to end lockdowns as new coronavirus infections drop, rather than waiting for vaccination rates to rise, risks triggering fresh restrictions and holding back the nation’s recovery, according to Oxford Economics.

“States are easing lockdowns based on lower test positivity rates rather than vaccination progress,” Priyanka Kishore, head of India and South East Asia Economics at Oxford Economics, wrote in a report to clients. “This risky strategy increases the chances of renewed outbreaks that would further delay the recovery.”

Provinces including national capital New Delhi have begun reopening amid signs of infections plateauing, causing mobility rates to improve as of mid-June. While that’s likely to foster return of some demand in the near-term, there’s the risk of consumption and business activity suffering going ahead should newer restrictions be placed to control a resurgent virus wave.


With only 3.9% of India’s population fully vaccinated, Kishore sees economically important states, including Maharashtra and Tamil Nadu not yet reaching the “safe” levels of vaccination.

“The vaccine situation keeps our outlook cautious,” said Kishore, who maintained India’s growth forecast for this year at 9.1% -- a pace slower than the 9.5% predicted by the nation’s central bank. “Economic data also doesn’t

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccineNew DelhiMaharashtraTamil Nadu

Next Story